5 reports of this reaction
2.0% of all ACETAMINOPHEN 500 MG reports
#10 most reported adverse reaction
LIVER FUNCTION TEST INCREASED is the #10 most commonly reported adverse reaction for ACETAMINOPHEN 500 MG, manufactured by Allegiant Health. There are 5 FDA adverse event reports linking ACETAMINOPHEN 500 MG to LIVER FUNCTION TEST INCREASED. This represents approximately 2.0% of all 253 adverse event reports for this drug.
Patients taking ACETAMINOPHEN 500 MG who experience liver function test increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LIVER FUNCTION TEST INCREASED is a less commonly reported adverse event for ACETAMINOPHEN 500 MG, but still significant enough to appear in the safety profile.
In addition to liver function test increased, the following adverse reactions have been reported for ACETAMINOPHEN 500 MG:
The following drugs have also been linked to liver function test increased in FDA adverse event reports:
LIVER FUNCTION TEST INCREASED has been reported as an adverse event in 5 FDA reports for ACETAMINOPHEN 500 MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
LIVER FUNCTION TEST INCREASED accounts for approximately 2.0% of all adverse event reports for ACETAMINOPHEN 500 MG, making it a notable side effect.
If you experience liver function test increased while taking ACETAMINOPHEN 500 MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.